Global PTA Balloon Catheter Market: Key Developments
The government authorities such as the U.S. Food and Drug Administration, European Commission, and others provide approval for the PTA balloon catheter products in respective regions.
For instance, Surmodics, Inc., a medical device company received the U.S. Food and Drug Administration (FDA) 510(k) and CE Mark clearance for its .014” low-profile percutaneous transluminal angioplasty (PTA) balloon dilation catheter in April 2018.
Furthermore, in September 2021, Medtronic plc. ,a medical device company, announced the CE mark approval and the European launch of the 200mm and 250mm IN.PACT Admiral drug-coated balloons (DCBs). The product is intended to treat long complex femoropopliteal lesions efficiently in patients with peripheral arterial disease.
PTA Balloon Catheter Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients